|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 10.42 USD | -1.79% |
|
-2.98% | +164.47% |
| 09-20 | Turn Therapeutics Inc.(NasdaqGM:TTRX) added to S&P TMI Index | CI |
| 09-09 | Turn Therapeutics Inc. Announces Appointment of Robert R. Redfield as Chief Scientific Officer | CI |
Evolution of the Average Target: Turn Therapeutics Inc.
Evolution of the Target Price: Turn Therapeutics Inc.
Changes in Analyst Recommendations: Turn Therapeutics Inc.
ee024cca90332bf9526ece735d26abc.fhNRdtwKh1RbBQpRZiUB-sKl9KHd8BL9aty7iBiqWgw.BmYBB-9i6hwiWk0XUkRmkajzzJCJsSqRXJ3d6iySOzs0SShEtXLzPQpuaQ~375c90d7c35eefa28c2d2595e68f3141
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
| - | +135.63% | |||||
| +34.22% | ||||||
| +28.94% | ||||||
| +9.74% | ||||||
| +10.62% | ||||||
| +17.69% | ||||||
| +40.75% | ||||||
| +41.74% | ||||||
| +30.99% | ||||||
| +4.58% | ||||||
| Average | +35.49% | |||||
| Weighted average by Cap. | +24.61% |


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.42USD
Average target price
25.00USD
Spread / Average Target
+139.92%
High Price Target
26.00USD
Spread / Highest target
+149.52%
Low Price Target
24.00USD
Spread / Lowest Target
+130.33%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- TTRX Stock
- Consensus Turn Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
















